Last Year's Winners
Admetsys is an innovative biomedical technology company that has developed the world’s first artificial pancreas system for use in hospital and surgical care. Admetsys’ treatment technology and supplementary remote monitoring products provide hospitals with full automation of glucose monitoring and treatment, significantly advancing the standard of diabetic control, and offering the precision and repeatability required by hospitals worldwide for this critical aspect of patient care.
Cupris provides a unique solution that enables clinical examination and communication through an app, web platform and smartphone-connected medical devices. The Cupris Health Platform enables the secure and patient-controlled sharing of medical history and clinical images to remotely receive a diagnosis or a second opinion and better monitor patients’ conditions.
VisusNano is a biotechnology start-up company that is developing a drug-eluting intraocular lens, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding a second surgical procedure, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Where they are now
Last year, more than 100 startups joined our Beanstalks Competition and they have made great progress !
Vopulus has launched its first product: Medics Academy, a platform that uses proprietary video technology to deliver specifically designed, high-quality courses and programmes to medical professionals. These contents can be accessed on any smartphone, tablet or computer anytime, anywhere. The company mission is to empower health professionals through knowledge so they can provide better care. The company has already developed and delivered a range of courses.
Onward is a Patient engagement platform that drives better healthoutcomes by partnering with Patients, Doctors, Physios. Onward Care helps postop patients improve their adherence to discharge instructions through superior patient engagement, remote monitoring & keeps them connected to the Hospital’s ecosystem. Onward Assist is a predictive analytics engine which helps providers reduce postop complications, as well as predicting recurrence of disease.
Nymbl Science is a global startup based in the UK and US. Nymbl provides the first and most comprehensive mobile and wearable technology-based solution to address the global healthcare challenge of decreasing balance and increasing falls in an ageing population.Since the GIANT Health Conference last year we have had an explosive 12 months! We are a finalist in the Prime Health $150k Challenge and will be presenting at the EXDO event centre, Denver CO on October 19th. Following the successful application for our second $50k Innovate UK grant, we’re developing a wearable to accurately measure gait to assess balance and predict falls. It complements our Nymbl Balance Evaluation and Training apps. We’ve begun a Validation Study of our balance system with Imperial College, London. At Summit Health, PA, we are partnering with GPs and PTs to validate the Nymbl solution and workflow within an outpatient setting. In a controlled trial with Summit, Nymbl participants improved their balance by 34% (vs control of 3.7%, p<0.001). And we are successfully implementing our recurring revenue model with balance improvement programmes in Senior Living Communities in the U.S.